Skip to main content
. Author manuscript; available in PMC: 2020 Jan 6.
Published in final edited form as: Am J Clin Oncol. 2008 Dec;31(6):557–560. doi: 10.1097/COC.0b013e318172d5de

TABLE 2.

Treatment and Symptom Information for 9 Patients Enrolled in Trial

Patient 1 2 3 4 5 6 7 8 9
Conventional vs. IMRT IMRT IMRT Con. then IMRT IMRT IMRT IMRT IMRT IMRT IMRT
Dose to oral tongue (Gy) 14–35 72 0 7–42 50 70 56–70 70 56–70
Symptoms
 Dysesthesia Slight X X X X X X
 Mucositis X X X X X X
 Gabapentin prescribed X X